This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review aims to assess the effect of metformin therapy on kidney function in patients with CKD. The safety and dose tolerability of metformin use in this population will also be assessed
Diabetes has been a prevalent disease worldwide, and metformin has been used widely as an oral hypog...
OBJECTIVE : This study was conducted to define a safe, effective dose regimen for metformin in moder...
This is the protocol for a review and there is no abstract. The objectives are as follows: to examin...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review ...
International audienceBackground/Aims: It has become clear that metformin exerts pleiotropic actions...
Over the past decades metformin has been the optimal first-line treatment for type 2 diabetes mellit...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review ...
Abstract: Current treatment strategies for chronic kidney disease (CKD) mainly focus on controlling ...
La metformine est reconnue comme le traitement de première intention dans le diabète de type 2 mais ...
We read with interest the paper by Adam et al. [1] which argues for less restrictive guidelines for ...
International audienceThis review mainly focuses on metformin, and considers oral antidiabetic thera...
Metformin is the most commonly prescribed drug for treating type 2 diabetes mellitus (T2D). Its mech...
Metformin, a well-known anti-diabetic agent, is very effective in lowering blood glucose in patients...
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:....
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a disorder of mineral and bone metabol...
Diabetes has been a prevalent disease worldwide, and metformin has been used widely as an oral hypog...
OBJECTIVE : This study was conducted to define a safe, effective dose regimen for metformin in moder...
This is the protocol for a review and there is no abstract. The objectives are as follows: to examin...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review ...
International audienceBackground/Aims: It has become clear that metformin exerts pleiotropic actions...
Over the past decades metformin has been the optimal first-line treatment for type 2 diabetes mellit...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review ...
Abstract: Current treatment strategies for chronic kidney disease (CKD) mainly focus on controlling ...
La metformine est reconnue comme le traitement de première intention dans le diabète de type 2 mais ...
We read with interest the paper by Adam et al. [1] which argues for less restrictive guidelines for ...
International audienceThis review mainly focuses on metformin, and considers oral antidiabetic thera...
Metformin is the most commonly prescribed drug for treating type 2 diabetes mellitus (T2D). Its mech...
Metformin, a well-known anti-diabetic agent, is very effective in lowering blood glucose in patients...
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:....
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a disorder of mineral and bone metabol...
Diabetes has been a prevalent disease worldwide, and metformin has been used widely as an oral hypog...
OBJECTIVE : This study was conducted to define a safe, effective dose regimen for metformin in moder...
This is the protocol for a review and there is no abstract. The objectives are as follows: to examin...